Your browser doesn't support javascript.
loading
Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort.
Idahl, Annika; Le Cornet, Charlotte; González Maldonado, Sandra; Waterboer, Tim; Bender, Noemi; Tjønneland, Anne; Hansen, Louise; Boutron-Ruault, Marie-Christine; Fournier, Agnès; Kvaskoff, Marina; Boeing, Heiner; Trichopoulou, Antonia; Valanou, Elisavet; Peppa, Eleni; Palli, Domenico; Agnoli, Claudia; Mattiello, Amalia; Tumino, Rosario; Sacerdote, Carlotta; Onland-Moret, N Charlotte; Gram, Inger T; Weiderpass, Elisabete; Quirós, Jose R; Duell, Eric J; Sánchez, Maria-Jose; Chirlaque, Maria-Dolores; Barricarte, Aurelio; Gil, Leire; Brändstedt, Jenny; Riesbeck, Kristian; Lundin, Eva; Khaw, Kay-Tee; Perez-Cornago, Aurora; Gunter, Marc J; Dossus, Laure; Kaaks, Rudolf; Fortner, Renée T.
Affiliation
  • Idahl A; Department of Clinical Sciences, Obstetrics and Gynecology, Umeå University, Umeå, Sweden.
  • Le Cornet C; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • González Maldonado S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Waterboer T; Infections and Cancer Epidemiology, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bender N; Infections and Cancer Epidemiology, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tjønneland A; Danish Cancer Society Research Center, Diet, Genes and Environment (DGE), Copenhagen, Germany.
  • Hansen L; Danish Cancer Society Research Center, Diet, Genes and Environment (DGE), Copenhagen, Germany.
  • Boutron-Ruault MC; CESP, Faculté de Médecine, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Fournier A; Gustave Roussy, Villejuif, France.
  • Kvaskoff M; CESP, Faculté de Médecine, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Boeing H; Gustave Roussy, Villejuif, France.
  • Trichopoulou A; CESP, Faculté de Médecine, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Valanou E; Gustave Roussy, Villejuif, France.
  • Peppa E; Department of Epidemiology, German Institute of Human Nutrition (DIfE) Potsdam-Rehbrücke, Nuthetal, Germany.
  • Palli D; Hellenic Health Foundation, Athens, Greece.
  • Agnoli C; Hellenic Health Foundation, Athens, Greece.
  • Mattiello A; Hellenic Health Foundation, Athens, Greece.
  • Tumino R; Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Cancer Risk Factors and Life-Style Epidemiology Unit, Florence, Italy.
  • Sacerdote C; Istituto Nazionale dei Tumori di Milano Via Venezian, Epidemiology and Prevention Unit Fondazione IRCCS, Milan, Italy.
  • Onland-Moret NC; Dipartimento di Medicina Clinica e Chirurgia, Federico II university, Naples, Italy.
  • Gram IT; Cancer Registry and Histopathology Department, "Civic - M.P. Arezzo" Hospital, ASP, Ragusa, Italy.
  • Weiderpass E; Unit of Cancer Epidemiology, Città Della Salute e Della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
  • Quirós JR; Julius Center for Health Sciences and Primary Care, UMC Utrecht, YOUth onderzoek - Universiteit Utrecht, Utrecht, The Netherlands.
  • Duell EJ; Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Sánchez MJ; International Agency for Research on Cancer, Lyon, France.
  • Chirlaque MD; J.S. Información Sanitaria, Dirección General de Salud Pública, Consejería de Sanidad, Oviedo, Spain.
  • Barricarte A; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
  • Gil L; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs.GRANADA. Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.
  • Brändstedt J; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Riesbeck K; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Lundin E; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
  • Khaw KT; Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain.
  • Perez-Cornago A; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Gunter MJ; Navarra Public Health Institute, Pamplona, Spain.
  • Dossus L; Navarra Institute for Health Research (IdiSNA) Pamplona, Spain.
  • Kaaks R; Public Health Division of Gipuzkoa, Research institute of BioDonostia, San Sebastian, Spain.
  • Fortner RT; Department of Clinical Sciences, Lund University, Division of Surgery, Skåne University Hospital, Lund, Sweden.
Int J Cancer ; 147(8): 2042-2052, 2020 10 15.
Article in En | MEDLINE | ID: mdl-32243586

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Chlamydia Infections / Sexually Transmitted Diseases / Chlamydia trachomatis Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Int J Cancer Year: 2020 Type: Article Affiliation country: Sweden

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Chlamydia Infections / Sexually Transmitted Diseases / Chlamydia trachomatis Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Int J Cancer Year: 2020 Type: Article Affiliation country: Sweden